The present study, for the first time, showed that ICA promoted the proliferation and osteogenic potency of BMSCs derived from OP patients with T2DM and identified the key effector gene GLI-1 of ICA based on sequencing and bioinformatic analyses. This evidence concerns the gene GLI1 and type 2 diabetes mellitus.